Montvale, NJ – July 5, 2017 – EmpiRx Health is excited to announce the implementation of its new Opioid Management Program to help reduce opioid abuse among its members. EmpiRx Health currently administers a comprehensive Fraud Waste and Abuse (FWA) Program that helps detect and address potentially fraudulent member and pharmacy activities, as well as waste and abuse cases.
“We have comprehensive protocols in place and have documented positive results based on our monitoring and analyses of our current FWA programs, however, given the rise in addiction and misuse of opioid medications such as Oxycodone, Hydrocodone, Morphine, and Methadone, we feel it is important to target and better manage opioids,” said Polina Kogan, RPh, PharmD, Vice President of Clinical Services.
Through this program, all new prescriptions for opioids will have a limited day supply for the initial fill. If the patient needs a higher day supply, a review for clinical appropriateness will be required. In addition, opioid prescriptions will only be filled for up to a maximum of a 30-day supply. These changes will help ensure the safety of EmpiRx Health members, limit excessive waste and produce cost savings for the plan.
About EmpiRx Health
EmpiRx Health is a full-service revolutionary pharmacy benefits management company founded by industry thought leaders in 2014. Their focus is simple: provide concierge service and proactive oversight to eliminate inefficiencies, maximize annual savings and preserve benefit dollars for today’s high-cost pharmacy benefits market. Headquartered in Montvale, NJ, EmpiRx Health uses their signature Pharmacy Care Management model to effectively manage gaps in service and provide superior clinical and financial solutions in an empirical manner. EmpiRx Health partners consultatively with brokers, consultants, third party administrators, employers and unions providing actionable information, customized reporting and advanced technology tools to achieve lower overall pharmacy costs.
SOURCE EmpiRx Health LLC